A Comparison of Remifentanil and Dexmedetomidine for Craniotomy Perioperative Hemodynamics and Postoperative Pain.
Phase of Trial: Phase II/III
Latest Information Update: 22 Dec 2016
At a glance
- Drugs Dexmedetomidine (Primary) ; Remifentanil (Primary)
- Indications Postoperative pain
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms RemivsDex
- 03 Jun 2016 Status changed from recruiting to completed.
- 11 Feb 2013 Planned End Date changed from 1 Mar 2012 to 1 Mar 2013 as reported by ClinicalTrials.gov.
- 19 Feb 2011 Additional trial investigators identified as reported by ClinicalTrials.gov.